摘要 |
A pharmaceutical compound of the formula <EMI ID=1.1 HE=66 WI=36 LX=1284 LY=410 TI=CF> <PC>in which the aminosulfonyl group is attached at the 3- or 4-position, and in which<BR> R<SB>1</SB> is hydrogen, C<SB>1-6</SB> alkyl, C<SB>3-10</SB> cycloalkyl, C<SB>3-10</SB> cycloalkyl-C<SB>1-4</SB> alkyl or optionally substituted phenyl-C<SB>1-4</SB> alkyl,<BR> R<SP>2</SP> is C<SB>1-6</SB> alkyl, C<SB>3-10</SB> cycloalkyl, C<SB>3-10</SB> cycloalkyl-C<SB>1-4</SB> alkyl, optionally substituted phenyl-C<SB>1-4</SB> alkyl or -(CH<SB>2</SB>)<SB>2</SB>NR<SP>5</SP>R<SP>6</SP> where R<SP>5</SP> and R<SP>6</SP> are each hydrogen or C<SB>1-6</SB> alkyl, and<BR> R<SP>3</SP> and R<SP>4</SP> are each C<SB>1-6</SB> alkyl, C<SB>3-10</SB> cycloalkyl, C<SB>3-10</SB> cycloalkyl-C<SB>1-4</SB> alkyl, C<SB>3-6</SB> alkenyl, optionally substituted phenyl or optionally substituted phenyl-C<SB>1-4</SB> alkyl,<BR> or R<SP>1</SP> and R<SP>2</SP>, or R<SP>3</SP> and R<SP>4</SP>, or R<SP>5</SP> and R<SP>6</SP>, together with the nitrogen atom to which they are attached, form a carbocyclic group containing 4 to 7 carbon atoms optionally substituted with one to three methyl or ethyl groups and optionally containing an oxygen atom or a further nitrogen atom, said carbocyclic group being optionally fused to an optionally substituted phenyl group;<BR> or a salt thereof. |